Cargando…

Inherited mutations in Chinese patients with upper tract urothelial carcinoma

Upper tract urothelial carcinoma (UTUC) accounts for 10% of urothelial carcinomas (UCs) and has a substantial hereditary component. However, the majority of our knowledge of germline spectrum comes from bladder cancer (BCa) data in White populations. Here, we sequence 309 Chinese UTUC cases and iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Junlong, Jin, Shengming, Gu, Chengyuan, Wei, Yu, Zhu, Yao, Necchi, Andrea, Shariat, Shahrokh F., Pan, Jian, Gan, Hualei, Dai, Bo, Zhang, Hailiang, Shi, Guohai, Zhu, Yu, Shen, Yijun, Zhu, Yiping, Ye, Dingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873949/ https://www.ncbi.nlm.nih.gov/pubmed/36630951 http://dx.doi.org/10.1016/j.xcrm.2022.100883

Ejemplares similares

Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas
por: Shang, Zhi, et al.
Publicado: (2022)

Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study
por: Jin, Shengming, et al.
Publicado: (2023)

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma
por: Wang, Beihe, et al.
Publicado: (2017)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

Plasma proteomic profiling discovers molecular features associated with upper tract urothelial carcinoma
por: Qu, Yuanyuan, et al.
Publicado: (2023)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Chang, Kun, et al.
Publicado: (2017)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2017)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
por: Wu, Junlong, et al.
Publicado: (2017)

Prognostic Value of Local Treatment in Prostate Cancer Patients With Different Metastatic Sites: A Population Based Retrospective Study
por: Jin, Shengming, et al.
Publicado: (2020)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

AB032. Penile rehabilitation using Vacuum Erection Device for erectile dysfunction after radical prostatectomy
por: Ye, Dingwei, et al.
Publicado: (2015)

Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma
por: Khene, Zine-Eddine, et al.
Publicado: (2016)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Outcomes of patients with lymph node metastasis treated with radical prostatectomy and adjuvant androgen deprivation therapy in a Chinese population: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
por: D’Andrea, David, et al.
Publicado: (2020)

NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer
por: Wu, Junlong, et al.
Publicado: (2017)

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature
por: Mbeutcha, Aurélie, et al.
Publicado: (2016)

Identification and validation of an 18-gene signature highly-predictive of bladder cancer metastasis
por: Wang, Beihe, et al.
Publicado: (2018)

ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A
por: Wang, Yuchen, et al.
Publicado: (2021)

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity
por: Wei, Yu, et al.
Publicado: (2023)

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer
por: Abudurexiti, MierXiati, et al.
Publicado: (2019)

SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression
por: Ma, Jian, et al.
Publicado: (2018)

Current Advances in Immune Checkpoint Inhibition and Clinical Genomics in Upper Tract Urothelial Carcinoma: State of the Art
por: Califano, Gianluigi, et al.
Publicado: (2022)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic
por: Zhu, Yu, et al.
Publicado: (2022)

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2016)

PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway
por: Wang, HongKai, et al.
Publicado: (2017)

Validation of Hyponatremia as a Prognostic Predictor in Multiregional Upper Tract Urothelial Carcinoma
por: Yeh, Hsin-Chih, et al.
Publicado: (2020)

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma
por: Zhang, Guiming, et al.
Publicado: (2015)

Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma
por: Wu, Kan, et al.
Publicado: (2020)

Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study
por: Abufaraj, Mohammad, et al.
Publicado: (2016)

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7t0u92gfvsk3j6l3e61sh7ceuk